ARCHIVES

Nexavar Phase III Trial Fails To Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable

November 20, 1998

Study Finds Relationship Between Meat Intake, Cancer

August 27, 2010

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

NIH Introduces “Modular” Gran Application And Awards

February 26, 1999

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997